Sara Alkner
41 – 45 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Prediction of outcome after diagnosis of metachronous contralateral breast cancer.
Alkner, Sara LU ; Bendahl, Pär-Ola LU ; Fernö, Mårten LU ; Manjer, Jonas LU and Rydén, Lisa LU
(2011)
In BMC Cancer
11.
- Contribution to journal › Article
- 2010
-
Mark
AIB1 is a predictive factor for tamoxifen response in premenopausal women.
Alkner, Sara LU ; Bendahl, Pär-Ola LU ; Grabau, Dorthe LU ; Lövgren, Kristina LU ; Stål, O ; Rydén, Lisa LU
and Fernö, Mårten
LU
(2010)
In Annals of Oncology
21.
p.238-244
- Contribution to journal › Article
-
Mark
Prediction of outcome after diagnosis of metachronous contralateral breast cancer
Alkner, Sara LU ; Bendahl, Pär-Ola LU ; Fernö, Mårten LU ; Manjer, Jonas LU and Ryden, Lisa LU
(2010)
San Antonio Breast Cancer Symposium 2010
In Cancer Research
70(Issue 24 suppl).
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.
Alkner, Sara LU ; Bendahl, Pär-Ola LU ; Fernö, Mårten LU ; Nordenskjöld, Bo and Rydén, Lisa LU
(2009)
In European Journal of Cancer
45.
p.2496-2502
- Contribution to journal › Article
- 2008
-
Mark
High amplified in breast cancer 1 is a significant predictor of improved response to adjuvant tamoxifen in premenopausal women
Rundquist, Sara LU ; Bendahl, Pär-Ola LU ; Grabau, Dorthe LU ; Lövgren, Kristina LU ; Stål, O ; Ryden, Lisa LU
and Fernö, Mårten
LU
(2008)
31st Annual San Antonio Breast Cancer Symposium
- Contribution to conference › Abstract